Reading Hospital and Medical Center Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4

Organization Overview

First Clinical Trial
2004
NCT00417872
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Reading Hospital | Reading Hospital Tower Health | The Reading Hospital and Medical Center

Active Ingredients

Drugs in Phase 4 Trials (1)

tranexamic acid (cyklokapron) (1 trial)

Drugs in Phase 2 Trials (2)

metronidazole (flagyl) (1 trial)

nitazoxanide (Alinia) (1 trial)

Drugs in Phase 1 Trials (1)

caffeine (1 trial)

Drugs in Other Trials (1)

ringer's lactate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Clostridium Infections (Phase 2)

Colitis (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5